GlassScriptPhysician profile
David L Kee
NPI 1992772289
$1,755.03
in general payments reported to CMS, 2019-2025
20 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $76.90 · 2021: $124 · 2022: $437 · 2023: $690 · 2024: $48.13 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $419.48 | 2021-2023 | Restrata Wound Matrix |
| Next Science LLC | $269.48 | 2023 | Blastx, Xperience, Surgx |
| Progenacare Global, LLC | $258.36 | 2023 | |
| Stryker Corporation | $200.13 | 2019-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Dart-Fire |
| Organogenesis INC. | $136.12 | 2019-2022 | |
| Biocomposites INC | $80.76 | 2025 | Stimulan |
| Paratek Pharmaceuticals, INC. | $53.49 | 2022-2023 | Nuzyra |
| Paragon 28, INC. | $52.90 | 2021-2022 | |
| Axogen | $45.16 | 2020-2021 | |
| Bioventus LLC | $40.59 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $39.48 | 2019-2020 | |
| In2bones USA, LLC | $27.31 | 2021 | |
| Smith+Nephew, INC. | $25.87 | 2025 | Renasys Go V2 Home, Pico 7 |
| Treace Medical Concepts, INC. | $20.12 | 2023 | |
| Melinta Therapeutics, LLC | $17.55 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossdsign USA Incorporated | $15.08 | 2025 | Ossdsign Catalyst |
| Astrazeneca Pharmaceuticals LP | $14.90 | 2025 | |
| Wright Medical Technology, INC. | $14.07 | 2020 | |
| Amgen INC. | $13.28 | 2024 | Krystexxa |
| Boston Scientific Corporation | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.